Journal
NATURE REVIEWS CANCER
Volume 3, Issue 9, Pages 666-U2Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc1167
Keywords
-
Categories
Funding
- Intramural NIH HHS [Z01 SC003811-32] Funding Source: Medline
Ask authors/readers for more resources
Adoptive immunotherapy - the isolation of antigen-specific cells, their ex vivo expansion and activation, and subsequent autologous administration - is a promising approach to inducing antitumour immune responses. The molecular identification of tumour antigens and the ability to monitor the persistence and transport of transferred cells has provided new insights into the mechanisms of tumour immunotherapy. Recent studies have shown the effectiveness of cell-transfer therapies for the treatment of patients with selected metastatic cancers. These studies provide a blueprint for the wider application of adoptive-cell-transfer therapy, and emphasize the requirement for in vivo persistence of the cells for therapeutic efficacy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available